Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)

Autor: Ducreux, M., Adenis, A., Pignon, J.-P., François, E., Chauffert, B., Ichanté, J.L., Boucher, E., Ychou, M., Pierga, J.-Y., Montoto-Grillot, C., Conroy, T.
Zdroj: In European Journal of Cancer April 2013 49(6):1236-1245
Databáze: ScienceDirect
Externí odkaz: